Do topical retinoids cause acne to "flare"?

Journal of Drugs in Dermatology

Volumn 8, Issue 9, 2009, Pages 799-801

  Yentzer, Brad A ^a   McClain, Richard W ^a   Feldman, Steven R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE; ISOTRETINOIN; RETINOIC ACID; TAZAROTENE; DERMATOLOGICAL AGENT; RETINOID;

ACNE; DISEASE EXACERBATION; DISEASE SEVERITY; DRY SKIN; ERYTHEMA; HUMAN; INTERNET; MEDLINE; REVIEW; SKIN IRRITATION; ACNE VULGARIS; CLINICAL TRIAL; HOSPITALIZATION; INTRADERMAL DRUG ADMINISTRATION; PATHOLOGY;

ACNE VULGARIS; ADMINISTRATION, CUTANEOUS; CLINICAL TRIALS AS TOPIC; DERMATOLOGIC AGENTS; HUMANS; RETINOIDS; SEVERITY OF ILLNESS INDEX;

EID: 70349335539     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Zaenglein AL, Thiboutot DM. Expert committee recommendations for acne management. Pediatrics. 2006;118(3):1188-1199. (Pubitemid 46090063)
2. Czernielewski J, Michel S, Bouclier M, Baker M, Hensby JC. Adapalene biochemistry and the evolution of a new topical retinoid for treatment of acne. J Eur Acad Dermatol Venereol. 2001;15(3):5-12. (Pubitemid 34036865)
3. Greenspan A, Loesche C, Vendetti N, et al. Cumulative irritation comparison of adapalene gel and solution with 2 tazarotene gels and 3 tretinoin formulations. Cutis. 2003;72(1):76-81. (Pubitemid 37229762)
4. Leyden J, Grove G, Zerweck C. Facial tolerability of topical retinoid therapy. J Drugs Dermatol. 2004;3(6):641-51.
5. Drug Digest. Available at: URL: http://www.drugdigest.org/DD/ DVH/Uses/0,3915,679|Tretinoin,00.html. Accessed April 17, 2008.
6. MedlinePlus. Tretinoin. Available at: URL: http://www.nlm.nih.gov/ medlineplus/druginfo/medmaster/a682437.html. Accessed April 17, 2008.
7. Chivot M. [Acne flare-up and deterioration with oral isotretinoin]. Ann Dermatol Venereol. 2001;128(3 Pt 1):224-228.
8. Thielitz A, Krautheim A, Gollnick H. Update in retinoid therapy of acne. Dermatol Ther. 2006;19(5):272-279. (Pubitemid 44470111)
9. Shalita A, Weiss JS, Chalker DK et al. A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris: A multicenter trial. J Am Acad Dermatol. 1996;34(3):482-485. (Pubitemid 26083828)
10. Tu P, Li GQ, Zhu XJ, Zheng J, Wong WZ. A comparison of adapalene gel 0.1% vs. tretinoin gel 0.025% in the treatment of acne vulgaris in China. J Eur Acad Dermatol Venereol. 2001;15 Suppl 3:31-36. (Pubitemid 34036869)
11. Cunliffe WJ, Poncet M, Loesche C, Verschoore M. A comparison of the efficacy and tolerability of adapalene 0.1% gel versus tretinoin 0.025% gel in patients with acne vulgaris: a meta-analysis of five randomized trials. Br J Dermatol. 1998;139 Suppl 52:48-56.
12. Pierard-Franchimont C, Henry F, Fraiture AL, et al. Split-face clinical and bio-instrumental comparison of 0.1% adapalene and 0.05% tretinoin in facial acne. Dermatology. 1999;198(2):218-222. (Pubitemid 29204622)
13. Cunliffe WJ, Caputo R, Dreno B et al. Clinical efficacy and safety comparison of adapalene gel and tretinoin gel in the treatment of acne vulgaris: Europe and U.S. multicenter trials. J Am Acad Dermatol. 1997;36(6 Pt 2):S126-S134. (Pubitemid 27265894)
14. Dominguez J, Hojyo MT, Celayo JL, et al. Topical isotretinoin vs. topical retinoic acid in the treatment of acne vulgaris. Int J Dermatol. 1998;37(1):54-55. (Pubitemid 28201875)
15. Ellis CN, Millikan LE, Smith EB, et al. Comparison of adapalene 0.1% solution and tretinoin 0.025% gel in the topical treatment of acne vulgaris. Br J Dermatol. 1998;139 Suppl 52:41-47.
16. Berger R, Rizer R, Barba A, et al. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial. Clin Ther. 2007;29(6):1086-1097. (Pubitemid 47198892)
17. Thiboutot D, Pariser DM, Egan N, et al. Adapalene gel 0.3% for the treatment of acne vulgaris: A multicenter, randomized, double-blind, controlled, phase III trial. J Am Acad Dermatol. 2006;54(2):242-250. (Pubitemid 43144393)
18. Pariser DM, Thiboutot DM, Clark SD, et al. The efficacy and safety of adapalene gel 0.3% in the treatment of acne vulgaris: A randomized, multicenter, investigator-blinded, controlled comparison study versus adapalene gel 0.1% and vehicle. Cutis. 2005;76(2):145-151. (Pubitemid 41290901)
19. Schlessinger J, Menter A, Gold M, et al. Clinical safety and efficacy studies of a novel formulation combining 1.2% clindamycin phosphate and 0.025% tretinoin for the treatment of acne vulgaris. J Drugs Dermatol. 2007;6(6):607-615.
20. Asselineau D, Bernard BA, Bailly C, et al. Human epidermis reconstructed by culture: is it "normal"? J Invest Dermatol. 1986;86(2):181-186.
21. Bouclier M, Chatelus A, Ferracin J, et al. Quantification of epidermal histological changes induced by topical retinoids and CD271 in the rhino mouse model using a standardized image analysis technique. Skin Pharmacol. 1991;4(2):65-73.
22. Hensby C, Cavey D, Bouclier M, et al. The in vivo and in vitro antiinflammatory activity of CD 271: A new retinoid-like modulator of cell differentiation. Pharmacol Skin. 1989;(3):160-162.
23. Opas EE, Bonney RJ, Humes JL. Prostaglandin and leukotriene synthesis in mouse ears inflamed by arachidonic acid. J Invest Dermatol. 1985;84(4):253-256. (Pubitemid 15109215)